Tilray Inc (NASDAQ:TLRY - Get Free Report) shares traded down 3.7% on Thursday . The company traded as low as $0.91 and last traded at $0.91. 16,658,641 shares changed hands during mid-day trading, a decline of 65% from the average session volume of 47,119,441 shares. The stock had previously closed at $0.95.
Wall Street Analyst Weigh In
Separately, Canaccord Genuity Group increased their price target on Tilray from $2.00 to $3.00 and gave the company a "buy" rating in a research note on Monday, January 13th. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $2.70.
Get Our Latest Analysis on Tilray
Tilray Stock Down 1.1 %
The company has a current ratio of 2.54, a quick ratio of 1.58 and a debt-to-equity ratio of 0.10. The stock has a market cap of $874.65 million, a P/E ratio of -3.11 and a beta of 2.07. The firm has a 50-day simple moving average of $1.20 and a two-hundred day simple moving average of $1.49.
Tilray (NASDAQ:TLRY - Get Free Report) last released its quarterly earnings data on Friday, January 10th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.03) by ($0.07). The business had revenue of $210.90 million during the quarter, compared to analyst estimates of $216.34 million. Tilray had a negative net margin of 30.95% and a negative return on equity of 4.40%. The firm's revenue was up 8.7% compared to the same quarter last year. Equities research analysts expect that Tilray Inc will post -0.2 earnings per share for the current fiscal year.
Institutional Trading of Tilray
Large investors have recently bought and sold shares of the business. Ferguson Wellman Capital Management Inc. acquired a new stake in Tilray in the third quarter valued at about $26,000. Lido Advisors LLC acquired a new stake in Tilray in the fourth quarter valued at about $28,000. Dudley Capital Management LLC acquired a new stake in Tilray in the fourth quarter valued at about $29,000. Verdence Capital Advisors LLC bought a new position in Tilray in the fourth quarter valued at about $29,000. Finally, International Assets Investment Management LLC raised its position in Tilray by 335.3% in the third quarter. International Assets Investment Management LLC now owns 23,639 shares of the company's stock valued at $42,000 after purchasing an additional 18,208 shares during the last quarter. 9.35% of the stock is owned by institutional investors and hedge funds.
Tilray Company Profile
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Further Reading
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
